ID   M3K3_HUMAN              Reviewed;         626 AA.
AC   Q99759; B2RCW2; D3DU15; Q5BKZ6; Q8N3I9;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   13-NOV-2007, sequence version 2.
DT   12-OCT-2022, entry version 217.
DE   RecName: Full=Mitogen-activated protein kinase kinase kinase 3;
DE            EC=2.7.11.25;
DE   AltName: Full=MAPK/ERK kinase kinase 3;
DE            Short=MEK kinase 3;
DE            Short=MEKK 3;
GN   Name=MAP3K3; Synonyms=MAPKKK3, MEKK3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION.
RX   PubMed=9006902; DOI=10.1074/jbc.272.5.2668;
RA   Ellinger-Ziegelbauer H.C., Brown K., Kelly K., Siebenlist U.;
RT   "Direct activation of the stress-activated protein kinase (SAPK) and
RT   extracellular signal-regulated protein kinase (ERK) pathways by an
RT   inducible mitogen-activated protein kinase/ERK kinase kinase 3 (MEKK)
RT   derivative.";
RL   J. Biol. Chem. 272:2668-2674(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Melanoma;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R., Gnerre S.,
RA   Goldstein S., Grafham D.V., Grocock R., Hafez N., Hagopian D.S., Hart E.,
RA   Norman C.H., Humphray S., Jaffe D.B., Jones M., Kamal M., Khodiyar V.K.,
RA   LaButti K., Laird G., Lehoczky J., Liu X., Lokyitsang T., Loveland J.,
RA   Lui A., Macdonald P., Major J.E., Matthews L., Mauceli E., McCarroll S.A.,
RA   Mihalev A.H., Mudge J., Nguyen C., Nicol R., O'Leary S.B., Osoegawa K.,
RA   Schwartz D.C., Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in the
RT   human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and PNS;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PHOSPHORYLATION AT SER-166 AND SER-337 BY SGK1.
RX   PubMed=12761204; DOI=10.1093/jb/mvg010;
RA   Chun J., Kwon T., Kim D.J., Park I., Chung G., Lee E.J., Hong S.K.,
RA   Chang S.I., Kim H.Y., Kang S.S.;
RT   "Inhibition of mitogen-activated kinase kinase kinase 3 activity through
RT   phosphorylation by the serum- and glucocorticoid-induced kinase 1.";
RL   J. Biochem. 133:103-108(2003).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH MAP2K5.
RX   PubMed=12912994; DOI=10.1074/jbc.c300313200;
RA   Nakamura K., Johnson G.L.;
RT   "PB1 domains of MEKK2 and MEKK3 interact with the MEK5 PB1 domain for
RT   activation of the ERK5 pathway.";
RL   J. Biol. Chem. 278:36989-36992(2003).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH TRAF6.
RX   PubMed=14661019; DOI=10.1038/ni1014;
RA   Huang Q., Yang J., Lin Y., Walker C., Cheng J., Liu Z.G., Su B.;
RT   "Differential regulation of interleukin 1 receptor and Toll-like receptor
RT   signaling by MEKK3.";
RL   Nat. Immunol. 5:98-103(2004).
RN   [10]
RP   FUNCTION, AND INTERACTION WITH TRAF7.
RX   PubMed=14743216; DOI=10.1038/ncb1086;
RA   Bouwmeester T., Bauch A., Ruffner H., Angrand P.-O., Bergamini G.,
RA   Croughton K., Cruciat C., Eberhard D., Gagneur J., Ghidelli S., Hopf C.,
RA   Huhse B., Mangano R., Michon A.-M., Schirle M., Schlegl J., Schwab M.,
RA   Stein M.A., Bauer A., Casari G., Drewes G., Gavin A.-C., Jackson D.B.,
RA   Joberty G., Neubauer G., Rick J., Kuster B., Superti-Furga G.;
RT   "A physical and functional map of the human TNF-alpha/NF-kappa B signal
RT   transduction pathway.";
RL   Nat. Cell Biol. 6:97-105(2004).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-250; SER-337 AND SER-340, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-250; SER-337 AND SER-340, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-337 AND SER-340, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-166; SER-250; SER-312;
RP   SER-337 AND SER-340, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   VARIANT [LARGE SCALE ANALYSIS] MET-281.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Component of a protein kinase signal transduction cascade.
CC       Mediates activation of the NF-kappa-B, AP1 and DDIT3 transcriptional
CC       regulators. {ECO:0000269|PubMed:12912994, ECO:0000269|PubMed:14661019,
CC       ECO:0000269|PubMed:14743216, ECO:0000269|PubMed:9006902}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.25;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.25;
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- ACTIVITY REGULATION: Activated by phosphorylation on Thr-530.
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Binds both upstream activators and downstream substrates in
CC       multimolecular complexes. Part of a complex with MAP2K3, RAC1 and CCM2.
CC       Interacts with MAP2K5 and SPAG9. {ECO:0000269|PubMed:12912994,
CC       ECO:0000269|PubMed:14661019, ECO:0000269|PubMed:14743216}.
CC   -!- INTERACTION:
CC       Q99759; Q9BSQ5-1: CCM2; NbExp=6; IntAct=EBI-307281, EBI-16157769;
CC       Q99759; Q13163: MAP2K5; NbExp=4; IntAct=EBI-307281, EBI-307294;
CC       Q99759; Q6Q0C0: TRAF7; NbExp=3; IntAct=EBI-307281, EBI-307556;
CC       Q99759; P31946: YWHAB; NbExp=2; IntAct=EBI-307281, EBI-359815;
CC       Q99759; P62258: YWHAE; NbExp=3; IntAct=EBI-307281, EBI-356498;
CC       Q99759; P61981: YWHAG; NbExp=3; IntAct=EBI-307281, EBI-359832;
CC       Q99759; Q04917: YWHAH; NbExp=3; IntAct=EBI-307281, EBI-306940;
CC       Q99759; P27348: YWHAQ; NbExp=2; IntAct=EBI-307281, EBI-359854;
CC       Q99759; P63104: YWHAZ; NbExp=2; IntAct=EBI-307281, EBI-347088;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q99759-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q99759-2; Sequence=VSP_035967;
CC   -!- PTM: Phosphorylation at Ser-166 and Ser-337 by SGK1 inhibits its
CC       activity. {ECO:0000269|PubMed:12761204}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. MAP kinase kinase kinase subfamily.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U78876; AAB41729.1; -; mRNA.
DR   EMBL; AK315305; BAG37709.1; -; mRNA.
DR   EMBL; AL834303; CAD38973.1; -; mRNA.
DR   EMBL; AC046185; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471109; EAW94297.1; -; Genomic_DNA.
DR   EMBL; CH471109; EAW94298.1; -; Genomic_DNA.
DR   EMBL; CH471109; EAW94299.1; -; Genomic_DNA.
DR   EMBL; BC090859; AAH90859.1; -; mRNA.
DR   EMBL; BC093672; AAH93672.1; -; mRNA.
DR   EMBL; BC093674; AAH93674.1; -; mRNA.
DR   CCDS; CCDS32701.1; -. [Q99759-2]
DR   CCDS; CCDS32702.1; -. [Q99759-1]
DR   RefSeq; NP_002392.2; NM_002401.3. [Q99759-1]
DR   RefSeq; NP_976226.1; NM_203351.1. [Q99759-2]
DR   PDB; 2C60; X-ray; 1.25 A; A=37-124.
DR   PDB; 2JRH; NMR; -; A=42-126.
DR   PDB; 2O2V; X-ray; 1.83 A; B=37-124.
DR   PDB; 2PPH; NMR; -; A=42-126.
DR   PDB; 4Y5O; X-ray; 2.35 A; B=1-124.
DR   PDB; 4YL6; X-ray; 2.10 A; B=1-22.
DR   PDBsum; 2C60; -.
DR   PDBsum; 2JRH; -.
DR   PDBsum; 2O2V; -.
DR   PDBsum; 2PPH; -.
DR   PDBsum; 4Y5O; -.
DR   PDBsum; 4YL6; -.
DR   AlphaFoldDB; Q99759; -.
DR   BMRB; Q99759; -.
DR   SMR; Q99759; -.
DR   BioGRID; 110379; 69.
DR   CORUM; Q99759; -.
DR   DIP; DIP-27521N; -.
DR   IntAct; Q99759; 40.
DR   MINT; Q99759; -.
DR   STRING; 9606.ENSP00000354927; -.
DR   BindingDB; Q99759; -.
DR   ChEMBL; CHEMBL5970; -.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugCentral; Q99759; -.
DR   iPTMnet; Q99759; -.
DR   PhosphoSitePlus; Q99759; -.
DR   BioMuta; MAP3K3; -.
DR   DMDM; 160332306; -.
DR   CPTAC; CPTAC-845; -.
DR   CPTAC; CPTAC-846; -.
DR   EPD; Q99759; -.
DR   jPOST; Q99759; -.
DR   MassIVE; Q99759; -.
DR   MaxQB; Q99759; -.
DR   PaxDb; Q99759; -.
DR   PeptideAtlas; Q99759; -.
DR   PRIDE; Q99759; -.
DR   ProteomicsDB; 78464; -. [Q99759-1]
DR   ProteomicsDB; 78465; -. [Q99759-2]
DR   Antibodypedia; 31306; 247 antibodies from 38 providers.
DR   DNASU; 4215; -.
DR   Ensembl; ENST00000361357.7; ENSP00000354927.3; ENSG00000198909.8. [Q99759-2]
DR   Ensembl; ENST00000361733.8; ENSP00000354485.4; ENSG00000198909.8. [Q99759-1]
DR   Ensembl; ENST00000579585.5; ENSP00000461988.1; ENSG00000198909.8. [Q99759-2]
DR   GeneID; 4215; -.
DR   KEGG; hsa:4215; -.
DR   MANE-Select; ENST00000361733.8; ENSP00000354485.4; NM_002401.5; NP_002392.2.
DR   UCSC; uc002jbe.4; human. [Q99759-1]
DR   CTD; 4215; -.
DR   DisGeNET; 4215; -.
DR   GeneCards; MAP3K3; -.
DR   HGNC; HGNC:6855; MAP3K3.
DR   HPA; ENSG00000198909; Low tissue specificity.
DR   MIM; 602539; gene.
DR   neXtProt; NX_Q99759; -.
DR   OpenTargets; ENSG00000198909; -.
DR   PharmGKB; PA30599; -.
DR   VEuPathDB; HostDB:ENSG00000198909; -.
DR   eggNOG; KOG0198; Eukaryota.
DR   GeneTree; ENSGT00940000158767; -.
DR   InParanoid; Q99759; -.
DR   OMA; DNRKECS; -.
DR   OrthoDB; 55144at2759; -.
DR   PhylomeDB; Q99759; -.
DR   TreeFam; TF105113; -.
DR   BRENDA; 2.7.11.25; 2681.
DR   BRENDA; 2.7.12.2; 2681.
DR   PathwayCommons; Q99759; -.
DR   Reactome; R-HSA-9020702; Interleukin-1 signaling.
DR   SignaLink; Q99759; -.
DR   SIGNOR; Q99759; -.
DR   BioGRID-ORCS; 4215; 13 hits in 1111 CRISPR screens.
DR   ChiTaRS; MAP3K3; human.
DR   EvolutionaryTrace; Q99759; -.
DR   GeneWiki; MAP3K3; -.
DR   GenomeRNAi; 4215; -.
DR   Pharos; Q99759; Tchem.
DR   PRO; PR:Q99759; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; Q99759; protein.
DR   Bgee; ENSG00000198909; Expressed in monocyte and 177 other tissues.
DR   ExpressionAtlas; Q99759; baseline and differential.
DR   Genevisible; Q99759; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004709; F:MAP kinase kinase kinase activity; TAS:ProtInc.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004672; F:protein kinase activity; IDA:MGI.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0001568; P:blood vessel development; IEA:Ensembl.
DR   GO; GO:0035556; P:intracellular signal transduction; IDA:MGI.
DR   GO; GO:0000165; P:MAPK cascade; TAS:ProtInc.
DR   GO; GO:2000773; P:negative regulation of cellular senescence; IMP:BHF-UCL.
DR   GO; GO:0090050; P:positive regulation of cell migration involved in sprouting angiogenesis; IGI:BHF-UCL.
DR   GO; GO:0071864; P:positive regulation of cell proliferation in bone marrow; IMP:BHF-UCL.
DR   GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEP:UniProtKB.
DR   GO; GO:1900745; P:positive regulation of p38MAPK cascade; IEA:Ensembl.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:MGI.
DR   CDD; cd06405; PB1_Mekk2_3; 1.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000270; PB1_dom.
DR   InterPro; IPR034879; PB1_MEKK2/3.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   Pfam; PF00564; PB1; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00666; PB1; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51745; PB1; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Kinase; Magnesium;
KW   Metal-binding; Nucleotide-binding; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..626
FT                   /note="Mitogen-activated protein kinase kinase kinase 3"
FT                   /id="PRO_0000086245"
FT   DOMAIN          44..123
FT                   /note="PB1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01081"
FT   DOMAIN          362..622
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          146..184
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          218..262
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        218..253
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        489
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         368..376
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         391
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         147
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61084"
FT   MOD_RES         166
FT                   /note="Phosphoserine; by SGK1"
FT                   /evidence="ECO:0000269|PubMed:12761204,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         250
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18691976,
FT                   ECO:0007744|PubMed:19369195, ECO:0007744|PubMed:23186163"
FT   MOD_RES         312
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         337
FT                   /note="Phosphoserine; by SGK1"
FT                   /evidence="ECO:0000269|PubMed:12761204,
FT                   ECO:0007744|PubMed:18691976, ECO:0007744|PubMed:19369195,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:23186163"
FT   MOD_RES         340
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18691976,
FT                   ECO:0007744|PubMed:19369195, ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         42
FT                   /note="Q -> QKKHNSSSSALLNSPTVTTSSCAGASEKKKFL (in isoform
FT                   2)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_035967"
FT   VARIANT         281
FT                   /note="V -> M (in dbSNP:rs36109904)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040685"
FT   VARIANT         325
FT                   /note="A -> G (in dbSNP:rs34042309)"
FT                   /id="VAR_037275"
FT   VARIANT         435
FT                   /note="A -> G (in dbSNP:rs9910858)"
FT                   /id="VAR_037276"
FT   CONFLICT        135
FT                   /note="G -> E (in Ref. 1; AAB41729)"
FT                   /evidence="ECO:0000305"
FT   HELIX           3..18
FT                   /evidence="ECO:0007829|PDB:4YL6"
FT   TURN            28..30
FT                   /evidence="ECO:0007829|PDB:2C60"
FT   STRAND          45..51
FT                   /evidence="ECO:0007829|PDB:2C60"
FT   STRAND          54..60
FT                   /evidence="ECO:0007829|PDB:2C60"
FT   HELIX           66..77
FT                   /evidence="ECO:0007829|PDB:2C60"
FT   STRAND          82..86
FT                   /evidence="ECO:0007829|PDB:2C60"
FT   HELIX           88..90
FT                   /evidence="ECO:0007829|PDB:4Y5O"
FT   STRAND          91..93
FT                   /evidence="ECO:0007829|PDB:2C60"
FT   HELIX           97..109
FT                   /evidence="ECO:0007829|PDB:2C60"
FT   TURN            111..114
FT                   /evidence="ECO:0007829|PDB:2JRH"
FT   STRAND          115..121
FT                   /evidence="ECO:0007829|PDB:2C60"
SQ   SEQUENCE   626 AA;  70898 MW;  28129168A57571DD CRC64;
     MDEQEALNSI MNDLVALQMN RRHRMPGYET MKNKDTGHSN RQSDVRIKFE HNGERRIIAF
     SRPVKYEDVE HKVTTVFGQP LDLHYMNNEL SILLKNQDDL DKAIDILDRS SSMKSLRILL
     LSQDRNHNSS SPHSGVSRQV RIKASQSAGD INTIYQPPEP RSRHLSVSSQ NPGRSSPPPG
     YVPERQQHIA RQGSYTSINS EGEFIPETSE QCMLDPLSSA ENSLSGSCQS LDRSADSPSF
     RKSRMSRAQS FPDNRQEYSD RETQLYDKGV KGGTYPRRYH VSVHHKDYSD GRRTFPRIRR
     HQGNLFTLVP SSRSLSTNGE NMGLAVQYLD PRGRLRSADS ENALSVQERN VPTKSPSAPI
     NWRRGKLLGQ GAFGRVYLCY DVDTGRELAS KQVQFDPDSP ETSKEVSALE CEIQLLKNLQ
     HERIVQYYGC LRDRAEKTLT IFMEYMPGGS VKDQLKAYGA LTESVTRKYT RQILEGMSYL
     HSNMIVHRDI KGANILRDSA GNVKLGDFGA SKRLQTICMS GTGMRSVTGT PYWMSPEVIS
     GEGYGRKADV WSLGCTVVEM LTEKPPWAEY EAMAAIFKIA TQPTNPQLPS HISEHGRDFL
     RRIFVEARQR PSAEELLTHH FAQLMY
//
